近来在动物模型中的研究表明胰高血糖素通过胰高血糖素受体在调节肝脏甘油三酯（TG）中发挥重要作用。
Recent studies in animal models suggest an important role for glucagon acting via the glucagon receptor in regulating hepatic triglyceride (TG) secretion.
本发明提供了具有胰高血糖素受体拮抗剂活性或反向激动剂活性的、新颖的式i化合物及其药学上可接受的盐和共晶体。
The present invention provides for novel compounds of Formula (I) and pharmaceutically acceptable salts and co-crystals thereof which have glucagon receptor antagonist or inverse agonist activity.
本发明涉及胰高血糖素样肽-1受体的多肽类激动剂的体外筛选方法及筛选得到的多肽。
The invention relates to a multi- peptide agonist vitro screening method of the glucagon peptide-1 receptor and the screened multi- peptide.
BYDUREON和百泌达(BYETTA)都属于胰高血糖素样肽(GLP - 1)受体激动剂类药物。
BYDUREON and BYETTA belong to the glucagon-like peptide-1 (GLP-1) receptor agonist class of medications.
BYDUREON和百泌达(BYETTA)都属于胰高血糖素样肽(GLP - 1)受体激动剂类药物。
BYDUREON and BYETTA belong to the glucagon-like peptide-1 (GLP-1) receptor agonist class of medications.
应用推荐